# Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter

> **NCT07237880** · NA · RECRUITING · sponsor: **Hillel Yaffe Medical Center** · enrollment: 184 (estimated)

## Conditions studied

- Labor, Induced

## Interventions

- **DRUG:** Papaverine 80 mg IV
- **DRUG:** Placebo (Normal Saline)

## Key facts

- **NCT ID:** NCT07237880
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2027-04-22
- **Final completion:** 2027-04-22
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07237880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07237880, "Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07237880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*